Figures
Abstract
Background
Data on the effects of intraoperative end-tidal carbon dioxide (EtCO2) levels on postoperative organ dysfunction are limited. Thus, this study was designed to investigate the relationship between the intraoperative EtCO2 level and postoperative organ dysfunction in patients who underwent major abdominal surgery under general anesthesia.
Methods
We conducted a cohort study involving patients who underwent major abdominal surgery under general anesthesia at Kyoto University Hospital. We classified those with a mean EtCO2 of less than 35 mmHg as low EtCO2. The time effect was determined as the minutes when the EtCO2 value was below 35 mmHg, whereas the cumulative effect was evaluated by measuring the area below the 35-mmHg threshold. The outcome was postoperative organ dysfunction, defined as a composite of at least one organ dysfunction among acute renal injury, circulatory dysfunction, respiratory dysfunction, coagulation dysfunction, and liver dysfunction within 7 days after surgery.
Results
Of the 4,171 patients, 1,195 (28%) had low EtCO2, and 1,428 (34%) had postoperative organ dysfunction. An association was found between low EtCO2 and increased postoperative organ dysfunction (adjusted risk ratio, 1.11; 95% confidence interval [CI], 1.03–1.20; p = 0.006). Additionally, long-term exposure to EtCO2 values of less than 35 mmHg (≥224 min) was associated with postoperative organ dysfunction (adjusted risk ratio, 1.18; 95% CI, 1.06–1.32; p = 0.003) and low EtCO2 severity (area under the threshold) (adjusted risk ratio, 1.13; 95% CI, 1.02–1.26; p = 0.018).
Citation: Dong L, Takeda C, Kamitani T, Hamada M, Hirotsu A, Yamamoto Y, et al. (2023) Association between intraoperative end-tidal carbon dioxide and postoperative organ dysfunction in major abdominal surgery: A cohort study. PLoS ONE 18(3): e0268362. https://doi.org/10.1371/journal.pone.0268362
Editor: Jörn Karhausen, Duke University, UNITED STATES
Received: April 26, 2022; Accepted: February 1, 2023; Published: March 10, 2023
Copyright: © 2023 Dong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The Institutional Review Board did not permit the sharing of our raw data (email: ethcom@kuhp.kyoto-u.ac.jp). In this paper, there are ethical reasons for restricting the data. To minimize the risk of leaking personal information, the data extracted from medical records does not include information that directly identifies individuals such as name and date of birth. However, when submitting an ethical application to the ethics committee, we stated that we will not provide samples or information to other research institutions regarding the provision of samples or information used in the research, and regarding records related to the provision of samples or information.
Funding: This work was supported in part by the Japan Society for the Promotion of Science KAKENHI program (grant number: 20K09242; principal investigator: Toshiyuki Mizota) and the 2019 Kyoto University ISHIZUE Research Development Program (principal investigator: Toshiyuki Mizota). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Although high-risk surgeries account for only 12.5% of all surgical procedures, they account for more than 80% of surgery-related deaths [1]. Intraoperative organ hypoperfusion is a cause of poor outcomes and may lead to high postoperative mortality [2]. Therefore, markers that can be used to monitor intraoperative organ hypoperfusion and predict postoperative organ injury are essential to improve postoperative outcomes.
The International Standards for a Safe Practice of Anesthesia recommend monitoring end-tidal carbon dioxide (EtCO2) using a capnograph during general anesthesia [3]. As EtCO2 involves all four components of respiration and circulation (i.e., ventilation, diffusion, circulation, and metabolism), it provides an excellent picture of the respiratory and circulatory processes. Under conditions of constant ventilation, EtCO2 can be used to monitor cardiac output and pulmonary blood flow [4, 5]. In fact, several studies have shown that EtCO2 is useful in predicting the effectiveness of resuscitation [6] and outcomes in patients with cardiopulmonary arrest (CPA) [7, 8] and in predicting cardiac output when the patient is weaned from cardiopulmonary bypass (CPB) [9, 10]. Similarly, EtCO2 in noncardiac surgery was associated with increased postoperative mortality [11] and prolonged postoperative length of hospital stay [11–13]. However, the association between EtCO2 and postoperative organ dysfunction in patients undergoing general surgical treatments has not yet been fully evaluated.
Therefore, we investigated the association between intraoperative EtCO2 and postoperative organ dysfunction in patients undergoing major abdominal surgery.
Methods
Study design, setting, and population
In this single-center cohort study, we used data from the IMProve Anesthesia Care and ouTcomes (Kyoto-IMPACT) database of Kyoto University Hospital. The Kyoto-IMPACT database aims to clarify the relationship between intraoperative respiratory and cardiovascular parameters and postoperative outcomes. We continuously selected patients who underwent surgery under the care of anesthesiologists at Kyoto University Hospital (1,121 beds). Several studies have been published using the Kyoto-IMPACT database [14, 15]. We included consecutive patients aged 18 years or older who underwent major abdominal surgery under general anesthesia at Kyoto University Hospital between March 2008 and December 2017. We included individuals who underwent abdominal surgery because major abdominal surgeries involve many cases, a long duration of surgery, and a high rate of postoperative organ dysfunction as outcomes. Major abdominal surgeries included laparoscopic or non-laparoscopic resections of the liver, colon, stomach, pancreas, and esophagus. The exclusion criteria were as follows: (1) patients with missing intraoperative EtCO2 data; (2) second or subsequent surgery in patients who had undergone multiple surgeries; (3) patients undergoing urological surgery, such as urinary tract unblocking, nephrectomy, and renal transplantation; (4) patients undergoing renal replacement therapy for end-stage renal disease (estimated glomerular filtration rate of < 15 ml.min-1.1.73 m2-1); (5) patients with a preoperative platelet count of less than 100 × 103 cells.μl-1; and (6) patients with a preoperative total bilirubin of more than or equal to 2.0 mg.dl-1.
Ethics
The Certified Review Board of Kyoto University (Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606–8501, Japan, Chairperson Prof. Shinji Kosugi) approved the study protocol (approval number: R1272-3; January 23, 2020) and waived the requirement for informed consent because of the nature of this study.
Data collection
We collected data from the Kyoto-IMPACT database using the anesthesia information management system and the electronic medical record system. EtCO2 was measured continuously using a sidestream gas analyzer (GF-220R Multigas/Flow Unit, Nihon Kohden®, Japan), which was uploaded automatically to the anesthesia information management system every 60 s. We defined intraoperative EtCO2 as the mean EtCO2 level from skin incision to skin closure. EtCO2 levels of less than 20 mmHg were removed as artifacts (EtCO2 during aspiration or position change). Definitions of variables, including the minimum and maximum EtCO2 values, can be found in S1 Table in S1 File. We collected data on patients’ postoperative course (e.g., acute renal injury [AKI], circulatory dysfunction, respiratory dysfunction, coagulation dysfunction, and liver dysfunction within 7 days postoperatively) from all clinical data contained in the electronic medical records. Ventilator data can be found in S8 Table in S1 File.
Exposure
To determine how the EtCO2 level affects postoperative organ dysfunction, exposure was defined by calculating the dose, time, and cumulative effects of EtCO2. Dose effects were assessed using the mean EtCO2; patients were divided into two groups based on the cutoff level of 35 mmHg, widely used lower limit of normal PaCO2 [16, 17]. We defined low EtCO2 patients as those with a mean EtCO2 of less than 35 mmHg, whereas we defined normal EtCO2 patients as those with a mean EtCO2 of more than or equal to 35 mmHg. The classification into one of these groups was used as the primary exposure for further analysis. Besides, we considered that the relationship between EtCO2 and postoperative organ dysfunction may not be linear; thus, mean EtCO2 values were classified into quartiles (i.e., <35, 35–37, 37–39, and ≥39 mmHg). To assess the effects of the duration and severity of low EtCO2 exposure, time effects were determined as the minutes when EtCO2 values were below 35 mmHg, and cumulative effects were assessed by measuring the area under the threshold of 35 mmHg for each patient. Additionally, we classified minutes and area under the EtCO2 35-mmHg threshold into quartiles, using the lowest quartile as the reference category.
Outcomes
Referring to a previous study [18], the primary outcome was a composite of at least one organ dysfunction among AKI (postoperative serum creatinine [SCr] levels increased more than 0.3 mg.dl-1 or 1.5 times more than preoperative SCr levels, defined by the Kidney Disease: Improving Global Outcome Acute Kidney Injury Work Group) [19], circulatory dysfunction (use of norepinephrine, epinephrine, and vasopressin and the administration of dopamine ≥5 μg.kg-1.min-1 and phenylephrine ≥50 μg.min-1), respiratory dysfunction (the need for invasive ventilation by endotracheal intubation or tracheostomy beyond 24 h postoperatively; does not include continuous positive airway pressure or noninvasive ventilation or scheduled reintubation, such as extubation within 24 h after reoperation), coagulation dysfunction (platelet count of < 100 × 103 cells.μl-1, i.e., a Sequential Organ Failure Assessment [SOFA] score of ≥2 points in the coagulation component) [20], and liver dysfunction (total bilirubin of ≥ 2.0 mg.dl-1, i.e., a SOFA score of ≥2 points in the liver component) 7 days after surgery [20]. Secondary outcomes were individual components of the primary composite outcome.
Statistical analyses
We planned to analyze the relationship between intraoperative EtCO2 and postoperative organ dysfunction before data collection. Continuous variables were expressed as the median and interquartile range (IQR), and categorical variables were expressed as counts and percentages (%).
First, we performed multivariate Poisson regression with robust variance estimate [21] to calculate the risk ratios for low EtCO2 (mean EtCO2 of < 35 mmHg) and postoperative organ dysfunction, using the normal EtCO2 (mean EtCO2 of ≥ 35 mmHg) as the reference category. Additionally, the risk ratios for the mean EtCO2 of the first quartile (mean EtCO2 of < 35 mmHg), third quartile (mean EtCO2 of 37–39 mmHg), and fourth quartile (mean EtCO2 of ≥39 mmHg) were calculated using the second quartile (mean EtCO2 of 35–37 mmHg) as the reference category because it is considered normocapnia. Furthermore, to examine the time and cumulative effects, we evaluated how each quartile affected postoperative organ dysfunction, with the first quartile of minutes under an EtCO2 of 35 mmHg and the area below the threshold EtCO2 of 35 mmHg as reference categories.
To demonstrate the relationship between intraoperative EtCO2 and postoperative organ dysfunction, we created four models using potential confounding factors that may be associated with the outcomes as follows. Model 1 included the covariates used for models 2, 3, and 4 and biologically and clinically essential data, including the body mass index, American Society of Anesthesiologists physical status (ASAPS), laparoscopic surgery, type of surgery, epidural anesthesia, and mean arterial pressure. In model 2, the covariates included in the AKI risk index were adjusted for age equal to or older than 56 years, male sex, emergency surgery, diabetes mellitus, active congestive heart failure, ascites, hypertension, and renal insufficiency [22]. In model 3, the covariates included in the Revised Cardiac Risk Index (RCRI) were adjusted for emergency surgery, surgery duration longer than 4 h, ischemic heart disease, congestive heart failure, cerebrovascular disease, diabetes, and perioperative SCr of more than 2.0 mg.dl-1 [23]. In model 4, the covariates included in the postoperative respiratory failure risk index (RFRI) were adjusted for age, emergency surgery, albumin level of less than 30 g.l-1, blood urea nitrogen level of more than or equal to 30 mg.dl-1, and chronic obstructive pulmonary disease (COPD) [24], except for partially or fully dependent status because of missing data. Additionally, we adjusted for the aforementioned multivariate regression models to investigate whether the dose, time, or cumulative effects of EtCO2 affected the secondary outcomes.
The categories of EtCO2 were treated as continuous variables, and the mean, minutes, and area under the threshold of categories were substituted into the multivariate Poisson regression model, with the median of each group as independent variables. A test of the linear trend was performed between the categories of EtCO2 and postoperative organ dysfunction, adjusted using the aforementioned model 1 (P for trend).
We performed a sensitivity analysis to assess the robustness of our findings. First, to assess the plausibility of the primary analysis, we performed a multivariate analysis using the sensitivity model described above as model 1: (i) patients for whom arterial gases were measured during surgery (ii) patients for whom minute ventilation data were available. For patients with intraoperative arterial gas measurements, the arterial partial pressure of carbon dioxide (PaCO2)-EtCO2 gradient was added to the covariates in model 1, defined as model 5, and the intraoperative maximum lactate value was added, defined as model 6, to investigate the relationship between intraoperative EtCO2 and postoperative organ dysfunction. Second, for patients for whom minute ventilation data were available, median minute ventilation was added to the covariates in model 1, defined as model 7 and multivariate analysis was performed. Finally we used the same multivariate regression models in subgroup analysis of laparoscopic versus open surgery. We calculated the crude risk ratio for postoperative organ dysfunction in each subgroup and tested the interaction between subgroups and EtCO2.
To maximize statistical power, all eligible patients in the Kyoto-IMPACT database were included in the analyses. To determine the statistical power, we predicted 4,500 eligible surgeries in our database in the 9 years, a risk ratio of 1.5 with postoperative organ dysfunction of 30% [18] and low EtCO2 proportion of 50% [25], resulting in an estimated power of 100%. We conducted complete case analysis because the percentage of missing data was 0.12%. All statistical tests were two-tailed. In all statistical analyses, Stata/SE 15.1 (StataCorp LLC, College Station, TX, USA) was used.
Results
Baseline patient characteristics
Among the 4,781 patients who underwent major abdominal surgeries between 2008 and 2017, 4,772 met the inclusion criteria and were included in the analyses (4,171 were complete cases) (Fig 1). Low EtCO2 (defined as a mean EtCO2 of < 35 mmHg) occurred in 28% of the patients included. Table 1 displays the characteristics of the study participants. The median EtCO2 level was 36 mmHg (IQR, 34–39 mmHg) for the entire population, 33 mmHg (IQR, 31–34 mmHg) for patients with low EtCO2, and 38 mmHg (IQR, 36–40 mmHg) for patients with normal EtCO2.
We included consecutive patients aged 18 years or older who underwent major abdominal surgery under general anesthesia at Kyoto University Hospital between 2012 and 2017. Then, we extracted the cases that met our eligibility criteria and analyzed them as complete cases.
Association between low EtCO2 and postoperative organ dysfunction
Table 2 shows the main results of this study. Postoperative organ dysfunction was observed in 41.67% (498 of 1,195 patients) in the low EtCO2 group compared with 31.25% (930 of 2,976 patients) in the normal EtCO2 group. The adjusted risk ratio by multivariate Poisson regression analysis for the low EtCO2 group (mean EtCO2 of < 35 mmHg) suggested an association between low EtCO2 and postoperative organ dysfunction (model 1 adjusted risk ratio, 1.11; 95% confidence interval [CI], 1.03–1.20; p = 0.006).
For further analysis, EtCO2 was divided into quartiles, and the second quartile (mean EtCO2 of 35–37 mmHg) was used as the reference and as the definition of low EtCO2 (the lowest quartile of the mean EtCO2 values [mean EtCO2 of < 35 mmHg]). Postoperative organ dysfunction decreased gradually from the first to the fourth quartiles (first quartile, 41.67%; second quartile, 36.75%; third quartile, 34.03%; and fourth quartile, 24.10%). The multivariate adjusted risk ratios were 1.08 (95% CI, 0.99–1.19) for the first quartile, 1.01 (95% CI, 0.90–1.12) for the third quartile, and 0.90 (95% CI, 0.80–1.01) for the fourth quartile, with the second quartile being used as the reference (p for trend = 0.002) (Table 2).
Regarding the time effect of EtCO2, compared with short-term exposure (first quartile of exposure time to EtCO2 of < 35 mmHg, 0–20 min), long-term exposure to EtCO2 levels of less than 35 mmHg (the fourth quartile of exposure time to EtCO2 of < 35 mmHg, 224–1,069 min) was associated with increased postoperative organ dysfunction (model 1 adjusted risk ratio, 1.18; 95% CI, 1.06–1.32; p = 0.003). Finally, for the cumulative effect of EtCO2, the fourth quartile of the area below the EtCO2 threshold of 35 mmHg (406–6,574 mmHg) was associated with increased organ dysfunction compared with the first quartile (model 1 adjusted risk ratio, 1.13; 95% CI, 1.02–1.26; p = 0.018).
Association between low EtCO2 and secondary outcomes
Table 3 shows the relationship between low EtCO2 and postoperative AKI (model 1 adjusted risk ratio, 1.04; 95% CI, 0.82–1.32; p = 0.712), postoperative circulatory dysfunction (model 1 adjusted odds ratio, 1.44; 95% CI, 0.79–2.60; p = 0.229), postoperative respiratory dysfunction (model 1 adjusted odds ratio, 2.19; 95% CI, 1.09–4.39; p = 0.026), postoperative coagulation dysfunction (model 1 adjusted risk ratio, 1.63; 95% CI, 1.39–1.91; p < 0.001), and postoperative liver dysfunction (model 1 adjusted risk ratio, 1.10; 95% CI, 0.99–1.21; p = 0.054). S2–S6 Tables in S1 File show the relationships between the quartiles of EtCO2 and secondary outcomes and the time and cumulative effects of EtCO2 on secondary outcomes.
Sensitivity analysis
In the sensitivity analysis, the association between low EtCO2 and postoperative organ dysfunction was observed even when the study was restricted to patients who had arterial gas measurements during surgery and for whom minute ventilation data were available. Even after adjusting for the PaCO2-EtCO2 gradient, intraoperative maximal lactate or minute ventilation, low EtCO2 was associated with increased postoperative organ dysfunction (S7 Table in S1 File). In the subgroup analysis of laparoscopic versus open surgery, the point estimates of the risk ratio for organ dysfunction were exceeded than 1 (S9 Table in S1 File).
Discussion
Overview of the results
In this cohort study, postoperative organ dysfunction occurred in 41.67% of the patients in the low EtCO2 group and in 31.25% of the patients in the normal EtCO2 group. We found that intraoperative EtCO2 was associated with a 1.11-fold increase in postoperative organ dysfunction.
Comparison with previous studies
Studies on EtCO2 have focused primarily on patients with CPA and assessed the usefulness of EtCO2 as a valuable tool that can assess the effectiveness of cardiopulmonary resuscitation (CPR) [6–9] and predict the outcome. This is because EtCO2 correlates well with cardiac output, and no other appropriate noninvasive methods exist to measure this important variable during CPR. Furthermore, although EtCO2 has been reported to correlate with cardiac output during withdrawal from CPB [10] and can predict volume responsiveness [26], studies have not evaluated the relationship between EtCO2 and clinical outcomes, and the mechanism of this association is unclear [10]. Some studies have reported that EtCO2 is associated with increased postoperative mortality [11] and prolonged postoperative length of hospital stay [12, 13], but the cause of death has not been evaluated, and the mechanism is unknown. Furthermore, no studies have focused on the association between intraoperative EtCO2 and postoperative organ dysfunction in patients undergoing general surgery. In this large cohort study, we could demonstrate a dose-dependent association between intraoperative EtCO2 and postoperative organ dysfunction using multivariate Poisson regression analysis in patients undergoing high-risk major abdominal surgeries.
Mechanism
As for the mechanism of the association between intraoperative EtCO2 and postoperative organ dysfunction, we interpreted that low cardiac output is associated with hypotension and low EtCO2, resulting in intraoperative hypoperfusion and postoperative organ dysfunction, when ventilation is constant during surgery. Additionally, even if blood pressure is stabilized by increasing peripheral vascular resistance to compensate for low cardiac output, low EtCO2 because of low cardiac output is associated with postoperative organ dysfunction, regardless of blood pressure. As an alternative to markers of cardiac output, such as cardiac output from pulmonary artery catheters or noninvasive cardiac output monitors, EtCO2 levels may provide an objective assessment of cardiac output and organ perfusion status.
Clinical implication
As EtCO2 is monitored regularly in patients undergoing general anesthesia, it may serve as an early indicator of intraoperative low cardiac output, organ hypoperfusion, and postoperative organ dysfunction. This study showed that even after adjusting for intraoperative blood pressure, EtCO2 was associated with postoperative organ dysfunction. Intraoperative EtCO2 values, along with other vital signs, can comprehensively assess a patient’s cardiac output and organ perfusion status in terms of ventilation, diffusion, circulation, and metabolism. As a practical clinical implication, EtCO2 may help make clinical decisions to optimize organ perfusion, such as whether vasoactive drugs should be added because of decreased afterload, inotropes should be added because of decreased preload, or fluids or blood transfusions should be given because of bleeding.
Strengths
This study has several strengths. First, this study investigated not only the dose effect of the mean EtCO2 level of less than 35 mmHg but also the effect of prolonged exposure to EtCO2 levels of less than 35 mmHg (≥224 min) and the severity of low EtCO2 exposure (area below the threshold). Second, we adjusted not only for various factors included in the existing AKI risk index, RCRI, and RFRI but also for various confounding factors, such as laparoscopic surgery, type of surgery, intraoperative blood pressure, and ASAPS in four models. Third, there were few missing data, and 99.9% of the cases were complete.
Limitations
This study has several limitations. First, the main analysis of this study did not consider the PaCO2–EtCO2 gap to calibrate EtCO2 concentrations using PaCO2 levels. PaCO2 is usually 2–5 mmHg higher than EtCO2 in healthy populations. Thus, this study underestimated the effect of low EtCO2 and overestimated the effect of hypercapnia. However, when restricted to patients with intraoperative arterial gas measurements, low EtCO2 was associated with increased postoperative organ dysfunction, even when PaCO2-EtCO2 gradient was adjusted. Second, as an unknown confounder, we did not know the potential reasons for anesthesiologists to target a specific EtCO2 level. Anesthesiologists’ interpretation of EtCO2 may influence their decisions regarding anesthesia management. Third, unmeasured confounding factors, such as smoking history, intraoperative medications, and intraoperative ventilation parameters, may have influenced the association between intraoperative EtCO2 and postoperative organ dysfunction. For example, hyperventilation is often indicated for patients with intraoperative hyperkalemia, which may lower the level of EtCO2, thus probably overestimating the effects of low EtCO2. Alternatively, it may underestimate the effects of low EtCO2 because of the intravenous administration of sodium bicarbonate in patients with acidosis, thus probably raising the level of EtCO2. Fourth, as this was an observation-based study, it does not show causality and could not confirm whether intraoperative management targeting an intraoperative EtCO2 level of 35 mmHg or higher reduces postoperative organ dysfunction.
Conclusion
In conclusion, in patients undergoing major abdominal surgery, intraoperative low EtCO2 levels of less than 35 mmHg were associated with increased postoperative organ dysfunction, suggesting that intraoperative EtCO2 is a predictor of postoperative organ dysfunction.
Supporting information
S1 Checklist. STROBE statement—Checklist of items that should be included in reports of observational studies.
https://doi.org/10.1371/journal.pone.0268362.s001
(DOC)
Acknowledgments
Assistance with the study: We are grateful to Mr. Yoshihiro Kinoshita, Ms. Tomoko Hosoya, and Mr. Yohei Taniguchi (Medical Information Systems Section, Management Division, Kyoto University Hospital, Kyoto, Japan) for their assistance in data collection for this study.
References
- 1. Gurgel ST, do Nascimento P Jr., Maintaining tissue perfusion in high-risk surgical patients: a systematic review of randomized clinical trials. Anesth Analg. 2011;112(6):1384–91. Epub 2010/12/16. pmid:21156979.
- 2. Parker T, Brealey D, Dyson A, Singer M. Optimising organ perfusion in the high-risk surgical and critical care patient: a narrative review. Br J Anaesth. 2019;123(2):170–6. Epub 2019/05/06. pmid:31054772; PubMed Central PMCID: PMC6676242.
- 3. Merry AF, Cooper JB, Soyannwo O, Wilson IH, Eichhorn JH. International Standards for a Safe Practice of Anesthesia 2010. Canadian journal of anaesthesia = Journal canadien d’anesthesie. 2010;57(11):1027–34. Epub 2010/09/21. pmid:20857254.
- 4. Isserles SA, Breen PH. Can changes in end-tidal PCO2 measure changes in cardiac output? Anesth Analg. 1991;73(6):808–14. Epub 1991/12/01. pmid:1952183.
- 5. Shibutani K, Muraoka M, Shirasaki S, Kubal K, Sanchala VT, Gupte P. Do changes in end-tidal PCO2 quantitatively reflect changes in cardiac output? Anesth Analg. 1994;79(5):829–33. Epub 1994/11/01. pmid:7978395.
- 6. Hubble MW, Van Vleet L, Taylor S, Bachman M, Williams JG, Vipperman R, et al. Predictive Utility of End-Tidal Carbon Dioxide on Defibrillation Success in Out-of-Hospital Cardiac Arrest. Prehospital Emergency Care. 2020:1–9. pmid:32986490
- 7. Wayne MA, Levine RL, Miller CC. Use of end-tidal carbon dioxide to predict outcome in prehospital cardiac arrest. Ann Emerg Med. 1995;25(6):762–7. Epub 1995/06/01. pmid:7755197.
- 8. Garnett AR, Ornato JP, Gonzalez ER, Johnson EB. End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation. Jama. 1987;257(4):512–5. Epub 1987/01/23. pmid:3098993.
- 9. Stine CN, Koch J, Brown LS, Chalak L, Kapadia V, Wyckoff MH. Quantitative end-tidal CO2 can predict increase in heart rate during infant cardiopulmonary resuscitation. Heliyon. 2019;5(6):e01871. pmid:31245640
- 10. Baraka AS, Aouad MT, Jalbout MI, Kaddoum RN, Khatib MF, Haroun-Bizri ST. End-tidal CO2 for prediction of cardiac output following weaning from cardiopulmonary bypass. The journal of extra-corporeal technology. 2004;36(3):255–7. Epub 2004/11/24. pmid:15559744.
- 11. Dony P, Dramaix M, Boogaerts JG. Hypocapnia measured by end-tidal carbon dioxide tension during anesthesia is associated with increased 30-day mortality rate. J Clin Anesth. 2017;36:123–6. Epub 2017/02/12. pmid:28183549.
- 12. Wax DB, Lin HM, Hossain S, Porter SB. Intraoperative carbon dioxide management and outcomes. European journal of anaesthesiology. 2010;27(9):819–23. Epub 2010/07/09. pmid:20613537.
- 13. Park J-H, Lee H-M, Kang CM, Kim KS, Jang CH, Hwang HK, et al. Correlation of Intraoperative End-Tidal Carbon Dioxide Concentration on Postoperative Hospital Stay in Patients Undergoing Pylorus-Preserving Pancreaticoduodenectomy. World Journal of Surgery. 2021. pmid:33591427
- 14. Mizota T, Dong L, Takeda C, Shiraki A, Matsukawa S, Shimizu S, et al. Invasive Respiratory or Vasopressor Support and/or Death as a Proposed Composite Outcome Measure for Perioperative Care Research. Anesth Analg. 2019;129(3):679–85. Epub 2019/08/20. pmid:31425207.
- 15. Mizota T, Dong L, Takeda C, Shiraki A, Matsukawa S, Shimizu S, et al. Transient acute kidney injury after major abdominal surgery increases chronic kidney disease risk and 1-year mortality. J Crit Care. 2019;50:17–22. Epub 2018/11/24. pmid:30469043.
- 16. Petran J, Ansems K, Rossaint R, Marx G, Kalvelage C, Kopp R, et al. Effects of hypercapnia versus normocapnia during general anesthesia on outcomes: a systematic review and meta-analysis. Brazilian Journal of Anesthesiology (English Edition). 2022;72(3):398–406. pmid:35644204
- 17. Way M, Hill GE. Intraoperative end-tidal carbon dioxide concentrations: what is the target? Anesthesiol Res Pract. 2011;2011:271539. Epub 2011/11/24. pmid:22110496; PubMed Central PMCID: PMC3202118.
- 18. Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, et al. Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial. Jama. 2017;318(14):1346–57. Epub 2017/10/04. pmid:28973220; PubMed Central PMCID: PMC5710560
- 19. Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clinical Practice. 2012;120(4):c179–c84. pmid:22890468
- 20. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22(7):707–10. pmid:8844239
- 21. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6. Epub 2004/03/23. pmid:15033648.
- 22. Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009;110(3):505–15. Epub 2009/02/13. pmid:19212261.
- 23. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043–9. Epub 1999/09/08. pmid:10477528.
- 24. Arozullah AM, Daley J, Henderson WG, Khuri SF. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program. Ann Surg. 2000;232(2):242–53. Epub 2000/07/21. pmid:10903604; PubMed Central PMCID: PMC1421137.
- 25. Akkermans A, van Waes JAR, Thompson A, Shanks A, Peelen LM, Aziz MF, et al. An observational study of end-tidal carbon dioxide trends in general anesthesia. Canadian journal of anaesthesia = Journal canadien d’anesthesie. 2019;66(2):149–60. Epub 2018/11/16. pmid:30430440; PubMed Central PMCID: PMC6331507.
- 26. Taggu A. Can Passive Leg Raising (PLR) Test Induced End-Tidal Carbon Dioxide (ETCO2) Changes Predict Fluid Responsiveness in Mechanically Ventilated Patients? CHEST. 2015;148(4):310A.